home / stock / incr.u:cc / incr.u:cc news

INCR.U:CC News and Press, Intercure Ltd. Ordinary Shares From 05/16/22

Stock Information
Company Name: Intercure Ltd. Ordinary Shares
Stock Symbol: INCR.U:CC
Market: TSXC
Website: intercure.co
Menu
INCR.U:CC INCR.U:CC Quote INCR.U:CC Short INCR.U:CC News INCR.U:CC Articles INCR.U:CC Message Board
Get INCR.U:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
INCR.U:CC - InterCure Begins 2022 with Record Breaking First Quarter Financial Results

Record revenue of $3 4 1 million in the first quarter of 2022 Adjusted EBITDA 2 increased almost 1 1 0% year-over-year to $8 million Net income of $ 6 million for the Q1 of 2022 compare d to ...
INCR.U:CC - InterCure to Release its Q1 2022 Results and Hold a Conference Call

NEW YORK and TORONTO and HERZLIYA, Israel, May 16, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that it plans to release financial results for the first quarter of 2022 after ...

INCR.U:CC - InterCure to Participate in Upcoming Investor Conferences in May 2022

NEW YORK, TORONTO, and HERZLIYA, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that that Alex Rabinovitch, Chief Executive Officer and Amos Cohen, Chief Financi...

INCR.U:CC - InterCure to Participate in A.G.P.'s Spring Consumer Cannabis Conference

NEW YORK and TORONTO and HERZLIYA, Israel, May 03, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will participate in Alliance Glo...
INCR.U:CC - InterCure Reports Record Breaking Q4 and 2021 Results - Exceeded Preliminary Results

Another record year with continued industry leading growth and profitability supported by focused strategy and execution Revenue growth expected to continue in the first quarter and throughout 2022 Strong balance sheet with $89 million cash supporting future profitable g...

INCR.U:CC - InterCure Expects to Publish its full Audited Fourth Quarter and Full Year 2021 Results Prior to the TSX Closing on April 5, 2022

Delay in publication of the Audited Results due to immaterial technical audit matters The Company expects the Audited Results will not differ from announced preliminary results NEW YORK and TORONTO and HERZLIYA, Israel, April 05, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd ...

INCR.U:CC - CORRECTING and REPLACING -- InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)

Fourth quarter 2021 Revenue and Adjusted EBITDA 2 of $33 million and $9 million, representing an increase of almost 200% and 140% YoY, respectively Record fiscal year 2021 revenue and Adjusted EBITDA 2 of $89 million and $23 million, representin...
INCR.U:CC - InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)

Fourth quarter 2021 Revenue and Adjusted EBITDA 2 of $33 million and $9 million, representing an increase of almost 200% and 140% YoY, respectively Record fiscal year 2021 revenue and Adjusted EBITDA 2 of $89 million and $23 million, representin...

INCR.U:CC - InterCure to Announce Q4 & Year-End 2021 Financial Results on April 4, 2022

Will release financial results for the fourth quarter of 2021 before market open on Monday, April 4, 2022 Webcast scheduled for same day at 8:30am ET NEW YORK, TORONTO, and HERZLIYA, Israel, April 03, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U...

INCR.U:CC - InterCure to Hold 2021 Q4 & Year-End Webcast

NEW YORK, TORONTO, and HERZLIYA, Israel, March 30, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that it plans to release financial results for the fourth quarter of 2021 afte...
Previous 10 Next 10